Evidence map›Paper›PMID 24192515›Full record

ArticleTransfusion2014

Isoprostane and isofuran lipid mediators accumulate in stored red blood cells and influence platelet function in vitro.

Sherry L Spinelli, Katie L Lannan, Ann E Casey, Amanda Croasdell, Timothy M Curran, Kelly F Henrichs, Stephen J Pollock, Ginger A Milne, Majed A Refaai, Charles W Francis and 2 more

Abstract read
In one paragraph

Article in Transfusion, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Red blood cell storage lesion: causes and potential clinical consequences.Blood transfusion = Trasfusione del sangue · 2019
    Review
  2. Article
  3. Observational
  4. Duration of red blood cell storage and inflammatory marker generation.Blood transfusion = Trasfusione del sangue · 2017
    Review
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Sherry L SpinelliDepartment of Pathology and Laboratory Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York.
Katie L Lannan
Ann E Casey
Amanda Croasdell
Timothy M Curran
Kelly F Henrichs
Stephen J Pollock
Ginger A Milne
Majed A Refaai
Charles W Francis
Richard P Phipps
Neil Blumberg
University of Rochester · USVanderbilt University · US

Funding

VISUAL INDICES OF NEUROTOXICITYP30ES001247 · NIEHS · UNIVERSITY OF ROCHESTER · PI Martha Susiarjo · 1985 to 2026
$42.8M
UNIVERSITY OF ROCHESTER'S RESEARCH ASSOCIATE ORGANIZATIONUL1RR024160 · NCRR · UNIVERSITY OF ROCHESTER · PI PEARSON, THOMAS ARTHUR · 2006 to 2011
$38.7M
Training in Environment ToxicologyT32ES007026 · NIEHS · UNIVERSITY OF ROCHESTER · PI Alison Elder, Marissa Sobolewski Terry · 1985 to 2026
$20.2M
The University of Rochester's Clinical and Translational Science InstituteUL1TR000042 · NCATS · UNIVERSITY OF ROCHESTER · PI BENNETT, NANCY M, KIEBURTZ, KARL D. · 2012 to 2015
$14.4M
Training Program in Oral ScienceT90DE021985 · NIDCR · UNIVERSITY OF ROCHESTER · PI OVITT, CATHERINE, YULE, DAVID I · 2011 to 2021
$5.6M
Identification and Significance of Biologic Mediators in Red Cell ConcentratesR01HL095467 · NHLBI · UNIVERSITY OF ROCHESTER · PI BLUMBERG, NEIL, PHIPPS, RICHARD P. · 2009 to 2012
$1.5M
BCL-2, ROS, AND CELL DEATH IN DEVELOPMENTAL TOXICITYR01ES007026 · NIEHS · UNIVERSITY OF WASHINGTON · PI MIRKES, PHILIP E · 1996 to 2002
$1.2M
Microparticles as Messengers of Communication Between Blood and Vascular CellsRC1HL100051 · NHLBI · UNIVERSITY OF ROCHESTER · PI PHIPPS, RICHARD P. · 2009 to 2010
$1.0M
NCATS NIH HHS UL1 TR000042NCRR NIH HHS UL1 RR024160NCRR NIH HHS UL1RR024160NHLBI NIH HHS HL095467NHLBI NIH HHS R01 HL095467NHLBI NIH HHS RC1 HL100051NHLBI NIH HHS RC1HL100051NIDCR NIH HHS T90 DE021985NIEHS NIH HHS ES007026NIEHS NIH HHS ES10247NIEHS NIH HHS P30 ES001247NIEHS NIH HHS R01 ES007026NIEHS NIH HHS T32 ES007026PHS HHS T32A1007285-25
6 · The paper itself

Abstract

backgroundStored red blood cells (RBCs) release hemoglobin (Hb) that leads to oxidative damage, which may contribute to thrombosis in susceptible transfusion recipients. Oxidative stress stimulates the generation of a new class of lipid mediators called F2 -isoprostanes (F2 -IsoPs) and isofurans (IsoFs) that influence cellular behavior. This study investigated RBC-derived F2 -IsoPs and IsoFs during storage and their influence on human platelets (PLTs). STUDY DESIGN AND

methodsF2 -IsoP and IsoF levels in RBC supernatants were measured by mass spectrometry during storage and after washing. The effects of stored supernatants, cell-free Hb, or a key F2 -IsoP, 8-iso-prostaglandin F2α (PGF2α ), on PLT function were examined in vitro.

resultsF2 -IsoPs, IsoFs, and Hb accumulated in stored RBC supernatants. Prestorage leukoreduction reduced supernatant F2 -IsoPs and IsoFs levels, which increased again over storage time. Stored RBC supernatants and 8-iso-PGF2α induced PLT activation marker CD62P (P-selectin) expression and prothrombotic thromboxane A2 release. Cell-free Hb did not alter PLT mediator release, but did inhibit PLT spreading. Poststorage RBC washing reduced F2 -IsoP and IsoF levels up to 24 hours.

conclusionsF2 -IsoPs and IsoFs are produced by stored RBCs and induce adverse effects on PLT function in vitro, supporting a potential novel role for bioactive lipids in adverse transfusion outcomes. F2 -IsoP and IsoF levels could be useful biomarkers for determining the suitability of blood components for transfusion. A novel finding is that cell-free Hb inhibits PLT spreading and could adversely influence wound healing. Poststorage RBC washing minimizes harmful lipid mediators, and its use could potentially reduce transfusion complications.

Indexed as

Blood PlateletsDinoprostErythrocytesF2-IsoprostanesFuransHumansImmunoassayIsoprostanesReactive Oxygen Species8-epi-prostaglandin F2alphaDinoprostF2-IsoprostanesfuranFuransIsoprostanesReactive Oxygen Species

Identifiers

PMID24192515
PMCPMC4010581
OpenAlexW1926393700

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.